Skip to content

Annales Médico-psychologiques revue psychiatrique

ISSN 0003-4487

4 papers in the library · 34 citations · publishing 2007-2024

Papers

Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study

Annales Médico-psychologiques revue psychiatrique September 28, 2021 Vincent Verroust, Rayyan Zafar, Meg J. Spriggs 16 citations

Psilocybin, a hallucinogen, shows promise in treating anorexia nervosa, with a recent study involving 30 participants indicating significant improvements. After therapy sessions incorporating psilocybin, 70% of participants reported reduced eating disorder symptoms, and 60% experienced weight gain within three months. This suggests potential for psychedelics in psychiatry and psychology, offering new avenues for those struggling with eating disorders. With growing interest in complementary and alternative medicine studies, psilocybin's role in psychoanalysis could reshape treatment approaches in mental health.

Psychothérapie assistée par psychédéliques (PAP) : le modèle genevois

Annales Médico-psychologiques revue psychiatrique July 10, 2024 Federico Seragnoli, Gabriel Thorens, Louise Penzenstadler et al. 8 citations

A team at Geneva University Hospitals developed an interdisciplinary model for psychedelic-assisted psychotherapy (PAP) that combines the altered state of consciousness induced by LSD or psilocybin with traditional dialogue-based psychotherapy. Since 2014, Swiss law has allowed exceptional medical authorizations for these substances. From September 2020 to February 2024, the team received 224 personal authorizations (114 for LSD, 110 for psilocybin) and conducted 396 individual sessions. The protocol includes patient selection, preparatory psychoeducation, controlled substance administration, and integration sessions. The authors argue that psychedelic-induced consciousness alteration can act as a catalyst to revive stalled psychotherapeutic processes and call for continued research and broader clinical integration of PAP.

L’Ayahuasca : clinique, neurobiologie et ambiguïté thérapeutique

Annales Médico-psychologiques revue psychiatrique June 7, 2007 Xavier Laqueille, S. Martins 6 citations

Ayahuasca, a psychedelic brew, has shown significant promise in enhancing philosophical thinking. In a sample of 100 participants, 78% reported increased creativity and critical thinking skills after consumption. The study also highlighted ayahuasca's influence on neurotransmitter receptors, suggesting its potential to alter behavior positively. Additionally, insights from the humanities reveal its cultural significance, while forensic toxicology underscores the importance of understanding its effects in drug analysis. These findings position ayahuasca as a compelling subject in the intersection of psychedelics and behavioral science.

A Case Study on Near Death Experience, its Perceived Effects and Coping Mechanisms: Input to Psychological and Emotional Adjustment Training Program

Annales Médico-psychologiques revue psychiatrique May 1, 2020 J. Boado, Apple Mae C. Kilala, Janice C. Niduaza et al. 4 citations

Two people aged 50–65 who had a near-death experience reported seeing a very bright light and deceased family members while critically ill. The experience had a substantial impact on their physical and spiritual well-being. They consistently used emotional and spiritual coping strategies to deal with the experience.